Intellia Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.

About NTLA

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. 

CEO
John M. Leonard
CEOJohn M. Leonard
Employees
485
Employees485
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2014
Founded2014
Employees
485
Employees485

NTLA Key Statistics

Market cap
3.91B
Market cap3.91B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
719.15K
Average volume719.15K
High today
$50.41
High today$50.41
Low today
$48.61
Low today$48.61
Open price
$49.54
Open price$49.54
Volume
197.73K
Volume197.73K
52 Week high
$130.33
52 Week high$130.33
52 Week low
$37.08
52 Week low$37.08

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
10.3%
Sell
3.4%

NTLA Earnings

-$1.96
-$1.31
-$0.65
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.